Prolira

Prolira is a Dutch healthcare technology and medical device company developing EEG-based brain monitoring tools for hospitalized patients at risk of acute encephalopathy and delirium. Its lead commercial product, the DeltaScan Brain State Monitor, is a bedside device that combines EEG measurements with a proprietary algorithm to provide an objective assessment of brain state in under five minutes. The company originated as a spin-off from Utrecht University Medical Centre and focuses on improving earlier detection of acute brain dysfunction, particularly in older hospitalized patients. Prolira has obtained U.S. FDA 510(k) clearance for the DeltaScan Monitor and DeltaScan Patch and also markets the system in Europe, positioning the company as a commercial-stage neurodiagnostics/medtech business serving hospitals.